(Q34550572)

3 August 2017

Medroxyprogesterone acetate exacerbates glutamate excitotoxicity (English)

1 reference

medroxyprogesterone acetate

3 August 2017

1 reference

1 reference

Jon Nilsen

1

1 reference

PubMed ID

16864144

3 August 2017

Alison Morales

series ordinal

2

1 reference

PubMed ID

16864144

3 August 2017

Roberta Diaz Brinton

series ordinal

3

1 reference

3 August 2017

1 July 2006

1 reference

Gynecological Endocrinology

3 August 2017

1 reference

3 August 2017

22

1 reference

3 August 2017

7

1 reference

3 August 2017

355-361

1 reference

Cellular and molecular mechanisms of estrogen regulation of memory function and neuroprotection against Alzheimer's disease: recent insights and remaining challenges

3 August 2017

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Clinical review 108: The molecular and neuroanatomical basis for estrogen effects in the central nervous system

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Neuroprotective effects of estrogens: potential mechanisms of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Estrogen and stroke: a balanced analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Effects of estrogen replacement therapy on PET cerebral blood flow and neuropsychological performance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Estrogen therapy in postmenopausal women: effects on cognitive function and dementia

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Hormone replacement therapy and incidence of Alzheimer disease in older women: the Cache County Study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Observations in a preliminary open trial of estradiol therapy for senile dementia-Alzheimer's type.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Estrogen protects primary cortical neurons from glutamate toxicity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Impact of progestins on estrogen-induced neuroprotection: synergy by progesterone and 19-norprogesterone and antagonism by medroxyprogesterone acetate

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Gender influences outcome of brain injury: progesterone plays a protective role.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Impact of progestins on estradiol potentiation of the glutamate calcium response

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

17beta-Estradiol Induction of Filopodial Growth in Cultured Hippocampal Neurons within Minutes of Exposure

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Impact of the selective estrogen receptor modulator, raloxifene, on neuronal survival and outgrowth following toxic insults associated with aging and Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Excitatory and inhibitory neurotransmitters in the generation and degeneration of hippocampal neuroarchitecture

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Calcium as sculptor and destroyer of neural circuitry

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Divergent impact of progesterone and medroxyprogesterone acetate (Provera) on nuclear mitogen-activated protein kinase signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Effects of combined oral conjugated estrogens and medroxyprogesterone acetate on brain infarction size after experimental stroke in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Increased risk of familial late-onset Alzheimer's disease in women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Cognitive deficits of men and women with Alzheimer's disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Cardiovascular health and disease in women

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

Oral contraceptives and the risk of breast cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F09513590600863337

10.1080/09513590600863337

21 January 2018

Identifiers

DOI

1 reference

3 August 2017

1 reference

PubMed ID

16864144